Nicholas Downing

Nicholas Downing

Director/Miembro de la Junta en FRAZIER LIFESCIENCES ACQUISITION CORPORATION .
41 años
Health Technology
Consumer Services
Technology Services

Perfil

Nicholas Sinclair Downing is currently a Director at Kestra Medical Technologies, Inc., Cardurion Pharmaceuticals, Inc., and River Renal Cos.
He is an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2022.
He is also a Partner at Bain Capital Life Sciences LP since 2018.
Formerly, Dr. Downing was a Director at HeartFlow, Inc. from 2023 to 2025 and a Consultant at McKinsey & Co., Inc. Education includes a doctorate from Yale School of Medicine conferred in 2014 and an undergraduate degree from Harvard College conferred in 2007.

Cargos activos de Nicholas Downing

EmpresasCargoInicio
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Director/Miembro de la Junta 01/11/2022
Inversor de Capital Privado 01/01/2020
Director/Miembro de la Junta -
Director/Miembro de la Junta -
River Renal Cos.
Director/Miembro de la Junta -

Antiguos cargos conocidos de Nicholas Downing.

EmpresasCargoFin
HEARTFLOW, INC. Director/Miembro de la Junta 07/08/2025
Consultor / Asesor -
Ver el detalle de la experiencia de Nicholas Downing.

Formación de Nicholas Downing.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

73

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Technology Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

River Renal Cos.

  1. Bolsa de valores
  2. Insiders
  3. Nicholas Downing